Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2131 |  ANAB AnaptysBio, Inc. - Common Stock | 57.03 USD | -1.23% | -2.80% | +5.36% | +62.02% | 1.66 B USD | ||
| 2140 |  VIR Vir Biotechnology, Inc. - Common Stock | 9.55 USD | -2.35% | +3.24% | +8.28% | +59.70% | 1.62 B USD | ||
| 2143 |  ABSI Absci Corporation - Common Stock | 8.96 USD | -6.18% | -1.32% | +15.46% | +243.30% | 1.54 B USD | ||
| 2148 |  FBRX Forte Biosciences, Inc. - Common Stock | 76.94 USD | +0.03% | +0.12% | +0.68% | +162.15% | 1.63 B USD | ||
| 2151 |  AAPG Ascentage Pharma Group International - American Depository Shar | 16.83 USD | -3.50% | -7.98% | -8.13% | -32.68% | 1.57 B USD | ||
| 2163 |  XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.58 USD | -1.38% | +2.51% | +2.14% | +10.28% | 1.56 B USD | ||
| 2165 |  BCAX Bicara Therapeutics Inc. - Common Stock | 23.29 USD | -2.55% | -4.24% | -14.88% | +61.29% | 1.54 B USD | ||
| 2177 |  TYRA Tyra Biosciences, Inc. - Common Stock | 25.50 USD | -2.11% | +0.59% | -17.18% | +77.82% | 1.52 B USD | ||
| 2186 |  LBRX LB Pharmaceuticals Inc - Common Stock | 47.47 USD | -0.31% | +0.15% | +34.78% | +149.84% | 1.53 B USD | ||
| 2191 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 96.27 USD | -7.10% | +8.88% | +16.54% | +19.47% | 1.42 B USD | ||
| 2192 |  INVA Innoviva, Inc. - Common Stock | 20.91 USD | -0.76% | -0.85% | -2.74% | +17.34% | 1.51 B USD | ||
| 2204 |  NVAX Novavax, Inc. - Common Stock | 8.36 USD | -6.49% | +4.24% | +7.73% | +6.50% | 1.38 B USD | ||
| 2209 |  ORIC Oric Pharmaceuticals, Inc. - Common Stock | 13.68 USD | -3.66% | +0.44% | +12.96% | +1.26% | 1.42 B USD | ||
| 2225 |  AVBP ArriVent BioPharma, Inc. - Common Stock | 28.77 USD | -1.20% | -1.00% | -9.70% | +39.80% | 1.42 B USD | ||
| 2243 |  CGEM Cullinan Therapeutics, Inc. - Common Stock | 21.39 USD | -1.34% | +4.90% | +22.58% | +162.45% | 1.38 B USD | ||
| 2244 |  OMER Omeros Corporation - Common Stock | 18.49 USD | -4.05% | +6.76% | +63.63% | +303.71% | 1.34 B USD | ||
| 2245 |  REPL Replimune Group, Inc. - Common Stock | 14.25 USD | -3.52% | 0.00% | +63.98% | +152.21% | 1.34 B USD | ||
| 2253 |  VOR Vor Biopharma Inc. - Common Stock | 22.14 USD | -5.22% | -1.91% | +14.01% | +69.01% | 1.31 B USD | ||
| 2257 |  MGTX MeiraGTx Holdings plc - Ordinary Shares | 13.80 USD | -3.77% | +2.60% | +14.43% | +57.71% | 1.33 B USD | ||
| 2270 |  JBIO Jade Biosciences, Inc. - Common Stock | 20.94 USD | -1.87% | -13.86% | +2.35% | +108.36% | 1.33 B USD |
Haberler Biotechnology Stocks
Deutsche Bank, argenx hissesini değerleme nedeniyle Tut’a düşürdü
Monte Rosa Therapeutics hissesi neden düşüyor?
Biomea Fusion hisseleri diyabet çalışması kayıt tamamlanmasıyla yükseldi
Monte Rosa hisseleri faz 2 prostat kanseri çalışması başlarken düştü
H.C. Wainwright, Biomea Fusion hissesi için hedef fiyatı korudu
Crinetics Pharmaceuticals hissesi 84,8 dolarda zirve yaptı
FDA, Capricor’un deramiocel incelemesini 22 Kasım’a uzattı
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |